Updated:
Cincinnati Children's Hospital Medical Center
Cincinnati Children's was founded in 1883 and operates today as one of the largest pediatric medical centers in the United States: a 700-plus-bed academic...
Cincinnati Children's Hospital Medical Center
Cincinnati Children's was founded in 1883 and operates today as one of the largest pediatric medical centers in the United States: a 700-plus-bed academic hospital that also serves as the Department of Pediatrics for the University of Cincinnati College of Medicine. Disclosed investments flow through Innovation Ventures, the hospital's technology-commercialization and venture arm led by Vice President Nick Archer. The office converts intellectual property generated by the institution's $300M-plus annual NIH-funded research base into equity in startup companies and licensing agreements. The investment posture is unusual among nonprofits — it functions as a direct, early-stage healthcare investor rather than as a passive limited partner in outside venture funds. Innovation Ventures targets medical devices, digital health platforms, therapeutics, and healthcare IT tools emerging from the hospital's own labs and clinical practice. The office builds early-stage companies around physician-inventor research and provides follow-on funding alongside institutional venture firms. Sectors of activity include pediatric medical devices and software, AI-enabled diagnostic tools, and novel cell and gene therapies — reflecting the research priorities of the hospital's 2,000-plus faculty investigators. Geographic deployment centers on the Midwest innovation corridor, with portfolio companies and licensing partners active nationally and in the UAE, where the hospital has a clinical-collaboration agreement with Abu Dhabi Health Services Company (SEHA) to establish a pediatric center of excellence. Firm leadership includes President and CEO Steve Davis, a physician-executive who has overseen the institution since 2010, and CFO Paul Jenny, who stewards the financial assets that underwrite the hospital's investment capacity. The hospital's broader asset footprint includes clinical and administrative properties across the Cincinnati metro region, including the main 3333 Burnet Avenue campus, a Liberty Township satellite, and the Brandon and Kelly Janszen building in Union, Kentucky. Philanthropy flows through the separate Cincinnati Children's Research Foundation, a parallel structure that raises private donor capital independent of the venture program's equity returns. The Schubert Society and William Cooper Procter Legacy Society serve as donor-recognition vehicles that underscore the firewall between grant-funded research and direct investment activity. What distinguishes this endowment from a standard healthcare-venture fund or a peer hospital's low-risk treasury strategy is the fact that capitalization for new ventures derives largely from embedded clinical and research assets rather than from a separate investment allocation pool. Spinoff companies are tested clinically within the hospital's own patient-care environment — a built-in form of due diligence that few other early-stage healthcare investors can replicate. The structure means deal sourcing is not market-competitive in the traditional sense; it is a proprietary pipeline gated by faculty invention disclosures, allowing the hospital to invest at the seed stage while assuming technical risk that is already partially de-risked through clinical use.
General information
Firm type
Endowment / Foundation
Year founded
1883
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Cincinnati
Corporate office
3333 Burnet Avenue, Cincinnati, OH, United States
Additional offices
Liberty Township, OH · Union Township, OH · Union, KY
Principals
Steve Davis
President and CEO
Paul Jenny
Senior Vice President and Chief Financial Officer
Nick Archer
Vice President of Innovation Ventures
Sector focus
Frequently asked questions
Who runs investment decisions at Cincinnati Children's?
Venture-investment decisions reside within Innovation Ventures, the hospital's technology-commercialization office. Nick Archer serves as Vice President of Innovation Ventures and manages the translational pipeline from faculty invention disclosures to equity stakes in spinoff companies. Overall financial and strategic authority rests with CFO Paul Jenny and President/CEO Steve Davis, per the institution's published leadership structure.
Does Cincinnati Children's invest as a limited partner in external venture funds, or only make direct investments?
The hospital's known investment posture is overwhelmingly direct. Innovation Ventures creates and capitalizes startup companies built around faculty discoveries, medical devices, and software platforms developed within the institution's clinical and research operations. There is no public evidence of a broad fund-of-funds or limited-partner portfolio in external venture capital firms.
How does Cincinnati Children's source proprietary deal flow?
Deal flow originates inside the hospital's own research enterprise, which is one of the largest pediatric-research operations in the United States, attracting more than $300 million in annual NIH funding. Faculty members disclose inventions through the hospital's technology-transfer process; Innovation Ventures evaluates those disclosures for commercial viability and funds the most promising through early-stage equity and licensing structures. The effect is a sourcing model gated by the hospital's own intellectual-property generation rather than by pitch meetings or broker introductions.
What sectors does Cincinnati Children's Innovation Ventures target?
The portfolio concentrates on healthcare verticals tied to pediatric research: medical devices for neonatal and pediatric care, digital health platforms and AI diagnostic tools, cell and gene therapies, and healthcare enterprise software. Investments flow directly from clinical needs observed inside the hospital's own 700-bed practice, which effectively anchors sector selection to specialties where Cincinnati Children's has published research and practicing physician-inventors.
How is the endowment's investment activity separated from the hospital's clinical mission?
The investment program operates through Innovation Ventures, a functionally distinct unit that manages equity and licensing economics under CFO Paul Jenny's oversight. Philanthropic fundraising runs through the separate Cincinnati Children's Research Foundation, which does not make venture-equity investments. Donor-recognition groups — the Schubert Society and William Cooper Procter Legacy Society — sit on the foundation side, structurally separated from the for-profit equity portfolio.
Does Cincinnati Children's maintain international investment or clinical partnerships?
Yes, the hospital has a disclosed business partnership with Abu Dhabi Health Services Company (SEHA) to establish a pediatric center of excellence in the UAE. While the partnership is primarily clinical and advisory, it represents a geographic extension of Cincinnati Children's brand and expertise that could influence international technology deployment and licensing activity.
What is Cincinnati Children's relationship with the University of Cincinnati?
Cincinnati Children's serves as the Department of Pediatrics for the University of Cincinnati College of Medicine. This academic affiliation underpins much of the research base that feeds Innovation Ventures' deal pipeline, as faculty hold joint appointments and conduct NIH-funded research through the hospital's research-arm infrastructure.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: